Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
Front Public Health. 2021 Nov 15;9:773175. doi: 10.3389/fpubh.2021.773175. eCollection 2021.
This study aimed to assess healthcare professionals' knowledge, attitudes, and concerns toward gene therapy in Saudi Arabia. We conducted an online cross-sectional survey via convenience sampling during the period from December 2018 to March 2019. A total of 419 (358 pharmacists and 61 physicians) responded to our questionnaire. Three hundred and nine (73.7%) were male, and the mean (±SD) age of 32.0 ± 7.7 years. The mean knowledge scores of all participants, pharmacists, and physicians were 3.8 ± 1.9, 3.8 ± 1.9, and 3.7 ± 1.9, respectively ( = 0.73). Higher knowledge score was associated with younger age (Coefficient: -0.03; = 0.02), male (Coefficient: 0.57; = 0.01), master's degree (Coefficient: 0.93; = 0.003) and Ph.D. holders (Coefficient: 1.10; = 0.01), and participants graduated from Canada (Coefficient: 2.10; = 0.01).Moreover, about half of the respondents (55%) were concerned about gene therapy, and genetics training at college was considered the best gene therapy education method by 69.4%. Attitude score was not significantly associated with the profession ( = 0.88) but positively correlated with the knowledge score (rho= 0.4; < 0.001). In conclusion, pharmacists and physicians showed limited knowledge with a positive attitude toward gene therapy. Therefore, educational programs on gene therapy need to be considered, focusing primarily on the safety, and social acceptance of such new therapeutic management.
本研究旨在评估沙特阿拉伯医疗保健专业人员对基因治疗的知识、态度和关注点。我们通过便利抽样于 2018 年 12 月至 2019 年 3 月期间进行了在线横断面调查。共有 419 名(358 名药剂师和 61 名医生)人对我们的问卷做出了回应。309 人(73.7%)为男性,平均年龄(±标准差)为 32.0±7.7 岁。所有参与者、药剂师和医生的平均知识得分为 3.8±1.9、3.8±1.9 和 3.7±1.9( = 0.73)。更高的知识得分与更年轻的年龄(系数:-0.03; = 0.02)、男性(系数:0.57; = 0.01)、硕士学位(系数:0.93; = 0.003)和博士学位持有者(系数:1.10; = 0.01)以及毕业于加拿大的参与者(系数:2.10; = 0.01)相关。此外,约一半的受访者(55%)对基因治疗表示担忧,69.4%的人认为在大学接受遗传学培训是基因治疗教育的最佳方法。态度得分与职业无显著相关性( = 0.88),但与知识得分呈正相关(rho=0.4; < 0.001)。综上所述,药剂师和医生对基因治疗的知识有限,但对其持积极态度。因此,需要考虑开展基因治疗教育计划,重点关注这种新治疗管理的安全性和社会接受度。